Cargando…
An Albumin-binding Polypeptide Both Targets Cytotoxic T Lymphocyte Vaccines to Lymph Nodes and Boosts Vaccine Presentation by Dendritic Cells
Rationale: Albumin-binding carriers have been shown to target cytotoxic T lymphocyte (CTL) vaccines to lymph nodes (LNs) and improve the efficacy of the vaccines. However, it was not clear whether the improved efficacy is solely due to the LN targeting, which prompted this study. Methods: First, we...
Autores principales: | Wang, Peng, Zhao, Peng, Dong, Shuyun, Xu, Tiefeng, He, Xiao, Chen, Mingnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743471/ https://www.ncbi.nlm.nih.gov/pubmed/29290804 http://dx.doi.org/10.7150/thno.21691 |
Ejemplares similares
-
A Comparison Study of iTEP Nanoparticle-Based CTL Vaccine Carriers Revealed a Surprise Relationship between the Stability and Efficiency of the Carriers
por: Dong, Shuyun, et al.
Publicado: (2016) -
Dendritic cell-glioma fusion activates T lymphocytes by elevating cytotoxic efficiency as an antitumor vaccine
por: Tian, Fuming, et al.
Publicado: (2014) -
Reducing cell number improves the homing of dendritic cells to lymph nodes upon intradermal vaccination
por: Aarntzen, Erik HJG, et al.
Publicado: (2013) -
Cytotoxic T Lymphocytes and Vaccine Development
por: Xiao, Zhengguo, et al.
Publicado: (2010) -
Regulation of Dendritic Cell Migration to the Draining Lymph Node: Impact on T Lymphocyte Traffic and Priming
por: Martín-Fontecha, Alfonso, et al.
Publicado: (2003)